Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
作者信息
Chua Kao-Ping, Conti Rena M
机构信息
Susan B. Meister Child Health Evaluation and Research Center, Department of Pediatrics, University of Michigan Medical School, Ann Arbor.
Questrom School of Business, Institute for Health System Innovation and Policy, Department of Markets, Public Policy, and Law, Boston University, Boston, Massachusetts.
出版信息
JAMA Intern Med. 2020 Oct 1;180(10):1273-1274. doi: 10.1001/jamainternmed.2020.2759.
Abstract
摘要
相似文献
1
Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.瑞德西韦用于治疗COVID-19的孤儿药指定的政策影响
JAMA Intern Med. 2020 Oct 1;180(10):1273-1274. doi: 10.1001/jamainternmed.2020.2759.
2
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.瑞德西韦的紧急使用授权：透明分配流程的必要性。
JAMA. 2020 Jun 16;323(23):2365-2366. doi: 10.1001/jama.2020.8863.
3
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.支持瑞德西韦治疗新型冠状病毒感染的论据。
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
4
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?我们用瑞德西韦（一种老药新包装）找到了治疗新冠病毒肺炎的万灵药了吗？
J R Coll Physicians Edinb. 2020 Jun;50(2):159-161. doi: 10.4997/JRCPE.2020.217.
5
Treatments for COVID-19: where are we now?2019冠状病毒病的治疗方法：我们目前处于什么阶段？
Br J Community Nurs. 2020 Aug 2;25(8):412-413. doi: 10.12968/bjcn.2020.25.8.412.
6
[Remdesivir for patients with COVID-19].[瑞德西韦用于新型冠状病毒肺炎患者]
Internist (Berl). 2020 Aug;61(8):869-872. doi: 10.1007/s00108-020-00836-7.
7
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.瑞德西韦：一种有前景的 COVID-19 大流行抗病毒候选药物：小型综述。
Eur J Med Chem. 2020 Sep 1;201:112527. doi: 10.1016/j.ejmech.2020.112527. Epub 2020 Jun 6.
8
Missed Opportunities on Emergency Remdesivir Use.瑞德西韦紧急使用中的错失机会
JAMA. 2020 Jul 28;324(4):331-332. doi: 10.1001/jama.2020.11932.
9
Repurposing antimalarials and other drugs for COVID-19.将抗疟药及其他药物重新用于治疗新冠肺炎。
Travel Med Infect Dis. 2020 Mar-Apr;34:101658. doi: 10.1016/j.tmaid.2020.101658. Epub 2020 Apr 2.
10
Uncertainty about the Efficacy of Remdesivir on COVID-19.瑞德西韦对COVID-19疗效的不确定性。
J Korean Med Sci. 2020 Jun 15;35(23):e221. doi: 10.3346/jkms.2020.35.e221.
引用本文的文献
1
Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?采用传统成本效益分析评估孤儿药的价值：是否合适？
Orphanet J Rare Dis. 2022 Apr 5;17(1):157. doi: 10.1186/s13023-022-02283-z.
Zotero 插件